IDEAYA Biosciences, Inc.
IDYA· Nasdaq
Quarterly figures for IDEAYA Biosciences, Inc., with source filings when available.
34 quarters. Mar 31, 2018 to Jun 30, 2026. USD.
IDEAYA Biosciences, Inc. has filed its 10-Q within 35 to 37 days of period end across its last 8 quarters. The 10-K runs 48 to 84 days.
IDEAYA Biosciences, Inc. · CIK 1676725 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | Aug 4, 2026 · pre-market | Aug 4, 2026 | 35 d | 10-Q | $8.86M | — | -$1.22 | |
| Q1 2026 |
|---|
| Mar 31, 2026 |
| May 5, 2026 · pre-market |
| May 5, 2026 |
| 35 d |
| 10-Q |
| $6.56M |
| — |
| -$1.11 |
| FY 2025 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2025derived | Dec 31, 2025 | Feb 17, 2026 · pre-market | Feb 17, 2026 | 48 d | 10-K | — | — | — | |
| Q3 2025 | Sep 30, 2025 | Nov 4, 2025 · pre-market | Nov 4, 2025 | 35 d | 10-Q | $207.83M | — | $1.33 | |
| Q2 2025 | Jun 30, 2025 | Aug 5, 2025 · pre-market | Aug 5, 2025 | 36 d | 10-Q | — | — | -$0.88 | |
| Q1 2025 | Mar 31, 2025 | May 6, 2025 · pre-market | May 6, 2025 | 36 d | 10-Q | — | — | -$0.82 | |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2024derived | Dec 31, 2024 | Feb 13, 2025 · pre-market | Feb 18, 2025 | 49 d | 10-K | $7.00M | +78.4% | — | |
| Q3 2024 | Sep 30, 2024 | Nov 4, 2024 · pre-market | Nov 4, 2024 | 35 d | 10-Q | $0.00 | −100.0% | -$0.60 | |
| Q2 2024 | Jun 30, 2024 | Aug 6, 2024 · pre-market | Aug 6, 2024 | 37 d | 10-Q | $0.00 | −100.0% | -$0.68 | |
| Q1 2024 | Mar 31, 2024 | May 7, 2024 · pre-market | May 7, 2024 | 37 d | 10-Q | $0.00 | −100.0% | -$0.53 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2023derived | Dec 31, 2023 | Feb 20, 2024 · pre-market | Feb 20, 2024 | 51 d | 10-K | $3.92M | −2.5% | — | |
| Q3 2023 | Sep 30, 2023 | Nov 7, 2023 · pre-market | Nov 7, 2023 | 38 d | 10-Q | $8.04M | −72.9% | -$0.46 | |
| Q2 2023 | Jun 30, 2023 | Aug 10, 2023 · pre-market | Aug 10, 2023 | 41 d | 10-Q | $3.54M | −39.4% | -$0.50 | |
| Q1 2023 | Mar 31, 2023 | May 9, 2023 · pre-market | May 9, 2023 | 39 d | 10-Q | $7.88M | −30.6% | -$0.49 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2022derived | Dec 31, 2022 | Mar 7, 2023 · pre-market | Mar 7, 2023 | 66 d | 10-K | $4.02M | +35.8% | — | |
| Q3 2022 | Sep 30, 2022 | Nov 8, 2022 · pre-market | Nov 8, 2022 | 39 d | 10-Q | $29.70M | +230.9% | $0.04 | |
| Q2 2022 | Jun 30, 2022 | Aug 15, 2022 · pre-market | Aug 15, 2022 | 46 d | 10-Q | $5.85M | −33.2% | -$0.57 | |
| Q1 2022 | Mar 31, 2022 | May 10, 2022 · pre-market | May 10, 2022 | 40 d | 10-Q | $11.36M | +56.7% | -$0.36 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2021derived | Dec 31, 2021 | Mar 15, 2022 · pre-market | Mar 18, 2022 | 77 d | 10-K | $2.96M | — | — | |
| Q3 2021 | Sep 30, 2021 | — | Nov 15, 2021 | 46 d | 10-Q | $8.98M | +0.1% | -$0.31 | |
| Q2 2021 | Jun 30, 2021 | — | Aug 10, 2021 | 41 d | 10-Q | $8.76M | — | -$0.33 | |
| Q1 2021 | Mar 31, 2021 | — | May 10, 2021 | 40 d | 10-Q | $7.25M | — | -$0.28 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2020derived | Dec 31, 2020 | — | Mar 23, 2021 | 82 d | 10-K | — | — | — | |
| Q3 2020 | Sep 30, 2020 | — | Nov 12, 2020 | 43 d | 10-Q | $8.97M | — | -$0.17 | |
| Q2 2020 | Jun 30, 2020 | — | Aug 12, 2020 | 43 d | 10-Q | — | — | -$0.59 | |
| Q1 2020 | Mar 31, 2020 | — | May 12, 2020 | 42 d | 10-Q | — | — | -$0.59 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2019 | Dec 31, 2019 | — | Mar 24, 2020 | 84 d | 10-K | — | — | -$0.53 | |
| Q3 2019 | Sep 30, 2019 | — | Nov 13, 2019 | 44 d | 10-Q | — | — | -$0.54 | |
| Q2 2019 | Jun 30, 2019 | — | Aug 12, 2019 | 43 d | 10-Q | — | — | -$1.30 | |
| Q1 2019 | Mar 31, 2019 | — | — | — | — | — | — | -$8.69 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q4 2018 | Dec 31, 2018 | — | — | — | — | — | — | -$8.11 | |
| Q3 2018 | Sep 30, 2018 | — | — | — | — | — | — | -$13.06 | |
| Q2 2018 | Jun 30, 2018 | — | — | — | — | — | — | -$7.47 | |
| Q1 2018 | Mar 31, 2018 | — | — | — | — | — | — | -$6.91 | |